Navigation Links
Cardium Launches New AWARE Clinical Study Website
Date:6/11/2008

SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) today announced the launch of a new website at http://www.anginaresearchstudy.com to provide patients, caregivers and physicians with information about the Company's Phase 3 AWARE clinical study. The AWARE study is evaluating the therapeutic effects of Generx(TM) for the potential treatment of myocardial ischemia (insufficient blood flow within the heart muscle) and associated angina due to coronary heart disease. Generx is designed to promote angiogenesis, a natural process of blood vessel growth within the heart muscle, following a one-time intracoronary infusion from a standard cardiac infusion catheter.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The AWARE (Angiogenesis in Women with Angina pectoris who are not candidates for Revascularization) study, a Phase 3 randomized, placebo-controlled, double-blind trial, is planned to enroll approximately 300 women with recurrent stable angina pectoris who are not candidates for revascularization and who are receiving optimal drug therapy. The primary endpoint is the improvement in time to onset of electrocardiogram changes diagnostic of myocardial ischemia during exercise treadmill testing at six months following administration. The secondary endpoints are improvement in myocardial blood flow within the affected heart muscle measured by adenosine SPECT imaging, as well as improvements in other measures of angina. The AWARE study is expected to include up to 50 U.S. clinical centers. Enrollment criteria, participating sites and other info
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
11. Novozymes Launches Enzyme to Reduce Acrylamide in Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Village, Calif. (PRWEB) January 15, 2014 ... treatment and management through the genomic analysis of tumor ... offer Therapy Finder™, a web-based cancer decision support application ... reporting option with Cynvenio’s ClearID™ genomic test, Therapy Finder ...
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 DTS Language ... its Online Web Portal for Life Science organizations who need ... specify the subject matter of their documents in advance with ... help reduce time-to-delivery of translations, often a critical factor in ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... -- The president of Cars.com and one ... and other Internet topics in the Sept. 29 inaugural speaker ... , ,The speaker, Mitch Golub, has an extensive background in ... joined Classified Ventures, which includes Cars.com, after a 21-year career ...
... Madison, Wis. - An improved warning system could ... representatives of a Madison company involved in emergency communications. ... the levees were breached, where people could have been ... said Kendall Post, chief technology officer of Madison-based ...
... Inc., has launched interactive, personalized services for Milwaukee ... the company announced Thursday. Traffic.com will provide area ... displays of roadway traffic conditions including congestion levels, ... in a news release. , ,Data for the ...
Cached Biology Technology:Cars.com president slated for Milwaukee event 2Madison company urges disaster warning upgrades 2
(Date:4/23/2014)... signing ceremony in Buenos Aires yesterday, Argentina joins ... associate member state. The move strengthens the ties ... communities. It grants Argentinian scientists access to EMBL,s ... collaborations. , "Ever since its inception, fostering excellent ... been at the core of EMBL,s mission," says ...
(Date:4/23/2014)... of the family of bacteria that causes whooping ... reveals surprising findings about the bacteria,s origin and ... strategies to control this respiratory disease, which kills ... of 343 strains of the Bordetella pertussis ... the last 100 years illustrates how vaccination has ...
(Date:4/23/2014)... social mammals, ravens form different types of social relationships ... they also form strict dominance relations. From a cognitive ... key ability in daily social life ("knowing who is ... members have with each other sets the stage for ... of this study have been published in the scientific ...
Breaking Biology News(10 mins):Impact of whooping cough vaccination revealed 2Ravens understand the relations among others 2
... (OTC,Bulletin Board: CICI) -- Communication Intelligence Corporation ("CIC" ... solutions for,the financial industry and the recognized leader ... for the fourth quarter,and the year ended December ... ended December 31, 2007 increased 63% to,$800,000, compared ...
... article entitled Passage Times for Polymer Translocation Pulled ... 5, of the Biophysical Journal, which is available online. ... Pulled through a Narrow Pore When polymeric ... a process known as translocation, they leave a distinct ...
... The growth in China,s carbon dioxide (CO2) emissions is ... atmospheric greenhouse gases even more difficult, according to a ... Berkeley, and UC San Diego. Previous estimates, including ... say the region that includes China will see a ...
Cached Biology News:Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 6Media highlights for February in Biophysical Journal 2Alarming growth in expected CO2 emissions in China, finds UC analysis 2Alarming growth in expected CO2 emissions in China, finds UC analysis 3
...
... with the xPONENT Software Interface is ... assays using Upstate's Beadlyte® reagents. This ... friendly xPONENT software developed by Luminex. ... for commercial or home-made multiplex kits. ...
... turntable. Provides up to 30 minutes of walkaway time. Automatic Calibration. Five minute ... RS-232 port. ... ... ...
Vybrant® Multidrug Resistance Assay Kit...
Biology Products: